Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of type 2 diabetes, surveyed endocrinologists and managed care organization's (MCOs) pharmacy directors agree that body weight loss is one of the attributes that most influences their decisions regarding prescribing and tier placement decisions.
↧